Use of Nutraceutical in Telogen Effluvium in Women: Results of a Prospective Clinical Observation

The study investigated the effectiveness of the nutriceutic "Alpenta" in treating telogen effluvium (TE) in 30 women over 12 weeks. Results showed a significant increase in the percentage of anagen hair from 73.1% to 84.8%, a 13.6% rise in terminal hair density, and an 11.2% increase in hair diameter. Clinical improvement was observed in 84.3% of participants, with 83.3% reporting reduced hair loss. The treatment was rated as "very good" or "good" in effectiveness by 80% of participants and was well-tolerated by 97%. The study concludes that "Alpenta" is a beneficial and well-tolerated treatment for women with acute or chronic TE.